A detailed history of Black Rock Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 381,694 shares of STIM stock, worth $530,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
381,694
Previous 380,544 0.3%
Holding current value
$530,554
Previous $1.81 Million 62.07%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.73 - $4.81 $1,989 - $5,531
1,150 Added 0.3%
381,694 $687,000
Q1 2024

May 10, 2024

BUY
$2.68 - $4.8 $1,112 - $1,992
415 Added 0.11%
380,544 $1.81 Million
Q4 2023

Feb 13, 2024

SELL
$1.05 - $2.9 $825 - $2,279
-786 Reduced 0.21%
380,129 $1.1 Million
Q3 2023

Nov 13, 2023

SELL
$1.29 - $2.22 $3,637 - $6,260
-2,820 Reduced 0.73%
380,915 $514,000
Q2 2023

Aug 11, 2023

BUY
$2.07 - $2.92 $10,592 - $14,941
5,117 Added 1.35%
383,735 $825,000
Q1 2023

May 12, 2023

SELL
$2.81 - $6.71 $114,223 - $272,754
-40,649 Reduced 9.7%
378,618 $1.1 Million
Q4 2022

Feb 13, 2023

BUY
$2.74 - $6.87 $8,110 - $20,335
2,960 Added 0.71%
419,267 $2.88 Million
Q3 2022

Nov 14, 2022

SELL
$2.35 - $4.66 $10,008 - $19,846
-4,259 Reduced 1.01%
416,307 $1.32 Million
Q2 2022

Aug 12, 2022

SELL
$2.09 - $3.71 $2.41 Million - $4.29 Million
-1,155,216 Reduced 73.31%
420,566 $1.35 Million
Q1 2022

May 12, 2022

SELL
$2.84 - $4.52 $53,082 - $84,483
-18,691 Reduced 1.17%
1,575,782 $4.77 Million
Q4 2021

Feb 10, 2022

BUY
$3.87 - $6.59 $88,131 - $150,074
22,773 Added 1.45%
1,594,473 $7.11 Million
Q3 2021

Nov 09, 2021

BUY
$6.22 - $15.54 $284,397 - $710,535
45,723 Added 3.0%
1,571,700 $10.3 Million
Q2 2021

Aug 11, 2021

BUY
$10.15 - $17.25 $15.5 Million - $26.3 Million
1,525,977 New
1,525,977 $24.4 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $37.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.